Sensing of Alzheimer's Disease and Multiple Sclerosis Using Nano-Bio Interfaces

J Alzheimers Dis. 2017;59(4):1187-1202. doi: 10.3233/JAD-160206.

Abstract

It is well understood that patients with different diseases may have a variety of specific proteins (e.g., type, amount, and configuration) in their plasmas. When nanoparticles (NPs) are exposed to these plasmas, the resulting coronas may incorporate some of the disease-specific proteins. Using gold (Au) NPs with different surface properties and corona composition, we have developed a technology for the discrimination and detection of two neurodegenerative diseases, Alzheimer's disease (AD) and multiple sclerosis (MS). Applying a variety of techniques, including UV-visible spectra, colorimetric response analyses and liquid chromatography-tandem mass spectrometry, we found the corona-NP complexes, obtained from different human serums, had distinct protein composition, including some specific proteins that are known as AD and MS biomarkers. The colorimetric responses, analyzed by chemometrics and statistical methods, demonstrate promising capabilities of the technology to unambiguously identify and discriminate AD and MS. The developed colorimetric technology might enable a simple, inexpensive and rapid detection/discrimination of neurodegenerative diseases.

Keywords: Alzheimer’s disease; colorimetric technology; disease-specific protein corona; gold nanoparticles; multiple sclerosis.

MeSH terms

  • Alzheimer Disease / blood*
  • Alzheimer Disease / diagnosis*
  • Citric Acid
  • Colorimetry
  • Cysteamine
  • Female
  • Gold
  • Humans
  • Male
  • Metal Nanoparticles / chemistry*
  • Multiple Sclerosis / blood*
  • Multiple Sclerosis / diagnosis*
  • Polyethylene Glycols
  • Protein Corona / metabolism*
  • Sensitivity and Specificity
  • Spectrometry, Fluorescence

Substances

  • Protein Corona
  • Citric Acid
  • Polyethylene Glycols
  • Cysteamine
  • Gold